SEC Form D filing

Rejuvenate Bio Inc

Biotech · Series B · Regulation D 506(b) · CA · Filed June 18, 2026

Websiterejuvenatebio.com

Offering amount: $27.0M
Exemption: Reg D 506(b)
Issuer state: CA
Filing date: June 18, 2026
Signature date: June 18, 2026
CIK: 0001859067

Summary

Auto-generated

Rejuvenate Bio Inc is a biotechnology company focused on gene therapies. The California-based issuer filed a $27.0M offering under Rule 506(b), indicating a series-b stage.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.